Syngene International Limited
SYNGENE.BO
Price:
$632.4
Market Cap:
$253.08B
Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, Japan, Europe, the United States, and internationally. The company provides discovery chemistry services, such as synthetic and medicinal chemistry, library and peptide synthesis, biomolecular science, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals; and chemical, formulation, analytical, and clinica...[Read more]
Industry
Biotechnology
IPO Date
2015-08-11
Stock Exchange
BSE
Ticker
SYNGENE.BO
PE Ratio
[54.38]
ROE
[9.97%]
Current Ratio
[1.72]
Dividend Yield
[0.20%]
Enterprise Value
[255.63B]
Dividend History
The ROE as of December 2025 (TTM) for Syngene International Limited (SYNGENE.BO) is 9.97%
According to Syngene International Limited’s latest financial reports and current stock price. The company's current ROE is 9.97%. This represents a change of 298.32% compared to the average of 2.50% of the last 4 quarters.
Syngene International Limited (SYNGENE.BO) Historical ROE (quarterly & annually)
How has SYNGENE.BO ROE performed in the past?
The mean historical ROE of Syngene International Limited over the last ten years is 15.84%. The current 9.97% ROE has changed -37.08% with respect to the historical average. Over the past ten years (40 quarters), SYNGENE.BO's ROE was at its highest in in the March 2016 quarter at 8.18%. The ROE was at its lowest in in the September 2025 quarter at 1.42%.
Average
15.84%
Median
15.60%
Minimum
10.50%
Maximum
22.87%
Syngene International Limited (SYNGENE.BO) ROE by Quarter and Year
Discovering the peaks and valleys of Syngene International Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 12.43%
Maximum Annual ROE = 22.87%
Minimum Annual Increase = -24.23%
Minimum Annual ROE = 10.50%
| Year | ROE | Change |
|---|---|---|
| 2025 | 10.50% | -12.36% |
| 2024 | 11.98% | -6.68% |
| 2023 | 12.84% | 6.94% |
| 2022 | 12.00% | -16.36% |
| 2021 | 14.35% | -24.23% |
| 2020 | 18.94% | 12.43% |
| 2019 | 16.85% | -5.10% |
| 2018 | 17.75% | -12.69% |
| 2017 | 20.33% | -11.11% |
| 2016 | 22.87% | 10.43% |
Syngene International Limited (SYNGENE.BO) Average ROE
How has SYNGENE.BO ROE performed in the past?
The current ROE of Syngene International Limited (SYNGENE.BO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
11.77%
5-year avg
12.33%
10-year avg
15.84%
Syngene International Limited (SYNGENE.BO) ROE vs. Peers
How is SYNGENE.BO’s ROE compared to its peers?
Syngene International Limited’s ROE is greater than Piramal Pharma Limited (-0.29%), less than Dr. Lal PathLabs Limited (24.29%), less than Dr. Lal PathLabs Limited (24.29%), less than Piramal Enterprises Limited (2.15%), less than J. B. Chemicals & Pharmaceuticals Limited (20.70%), less than J. B. Chemicals & Pharmaceuticals Limited (20.70%), less than Inventurus Knowledge Solutions Ltd. (33.89%), less than Sagility India Limited (9.57%), less than Sagility India Limited (9.57%), less than Inventurus Knowledge Solutions Ltd. (33.89%),
| Company | ROE | Market cap |
|---|---|---|
| -0.29% | $229.09B | |
| 24.29% | $242.35B | |
| 24.29% | $242.97B | |
| 2.15% | $254.86B | |
| 20.70% | $282.28B | |
| 20.70% | $282.94B | |
| 33.89% | $264.49B | |
| 9.57% | $230.46B | |
| 9.57% | $230.32B | |
| 33.89% | $264.12B |
Build a custom stock screener for Syngene International Limited (SYNGENE.BO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Syngene International Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Syngene International Limited (SYNGENE.BO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Syngene International Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Syngene International Limited's ROE?
How is the ROE calculated for Syngene International Limited (SYNGENE.BO)?
What is the highest ROE for Syngene International Limited (SYNGENE.BO)?
What is the 3-year average ROE for Syngene International Limited (SYNGENE.BO)?
What is the 5-year average ROE for Syngene International Limited (SYNGENE.BO)?
How does the current ROE for Syngene International Limited (SYNGENE.BO) compare to its historical average?